Paragon Care Limited’s (ASX: PGC) shares mounted on ASX post completion of first tranche placement to China Pioneer

paragon care limited

Paragon Care Limited’s (ASX: PGC) shares climbed up 2.083 percent on September 17, 2018 after the completion of first tranche placement to China Pioneer Pharma holdings limited wherein PGC has issued 16,483,517 fully paid ordinary shares to Pioneer Pharma Australia Pty Limited, as a wholly owned subsidiary of Stock exchange of Hong Kong-listed China Pioneer Pharma Holdings Limited at a price of AU$0.91 per share. Following the completion of tranche 1 of the placement, China Pioneer will hold 5.45% of the 302,187,703 issued shares of Paragon. Further, the balance of 33,934,869 will be settled and allotted on or before 20 November 2018 under Tranche 2 placement program. Moreover, the company announced the resignation of Mr. Leonard Kocovic as Joint Company secretary while Ms. Melanie Leydin will continue in her capacity as Company Secretary to the Board. 

For the year-end 30 June 2018, the company has reported revenue of $136.7 Mn and EBITDA of $19.7 Mn. The company is having a net debt of $64.4 million compared to $18.5 million a year ago. Paragon care’s net cash flow from operating activities is $7.6 million compared to 12.0 million a year ago. The company has successfully completed 9 acquisitions which have resulted in stronger and diversified business. Besides this, the company focuses on to build a people and infrastructure platform to support a $1bn revenue business. For that matter, during FY18, the company invested in Sales team growth, IT infrastructure and driving cost selling opportunities. Moreover, the company is executing its tightened strategy with a new CEO in place and multiple board changes.

The company is focused on potential mergers and acquisition opportunities to accelerate growth in customer base and geographies which are in line with the Company’s strategy. In FY 2018, the company announced a financial dividend of 2.0c (fully franked) which reflects an increase over the full year of 5.0%. This year EPS of 5.4cps is reflecting the acquisitions and recent capital raising timing in the second half of the financial year.

PGC’s shares traded at $0.735 at the market capitalization of circa $205.71 Mn as of 17 September 2018 (AEST 2:46 PM).

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

Sponsored ad by Kalkine

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here